Moustafa Gabr

Weill Cornell Medicine

NIH Rank #1347
  • R01 Holder
  • Top 10% Funded
  • Early Career

NIH Funding · FY2024

Total Funding
$4.5M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#1,347
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $4.5M across 5 grants · National rank #1347.

Top grants by award amount

Moustafa Gabr's NIH grant portfolio, ranked by award amount.

  • 1RF1AG084635-01A1RF1
    Small molecule inhibitors of CAPON-induced tau aggregation
    $2M
    award amount
  • 1R01AG083512-01A1R01
    Discovery of first-in-class small molecule TREM2 ligands as therapeutics for Alzheimer's disease
    $768.3K
    award amount
  • 1R01DK137299-01A1R01
    Optimization of small molecule immunomodulators as combination therapy for IBD
    $672.4K
    award amount
  • 1R01CA293456-01R01
    Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma
    $547.7K
    award amount
  • 1R01NS136524-01R01
    CHI3L1-targeted small molecules for glioblastoma
    $502.6K
    award amount

Affiliation

Institutions that have administered grants for Moustafa Gabr.

Affiliated with Weill Cornell Medicine (NY).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Weill Cornell Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1347
  6. 2024
    Entered Top 25% Nationally
    Ranked #1347
  7. 2024
    Entered Top 10% Nationally
    Ranked #1347